GET THE APP

..

Journal of Blood & Lymph

ISSN: 2165-7831

Open Access

Interleukin-8 as a Surrogate Marker in Risk Stratification of Patients with Acute Myeloid Leukemia

Abstract

Mohammed Abdul Wahid Almorish, Waiel Mohmed Abdo Al-Kahiry, Maha Abubakr Feissal Rabie and Enas Ali Mohamed Dammag

Introduction: When molecular and cytogenetic studies are not available, the risk stratification of AML patients will be difficult. This study was conducted to evaluate the prognostic value of IL-8 among AML patients with its relation to outcome.

Methods: This is a cross sectional study; 42 newly diagnosed AML patients (<65 years) were investigated with determination of serum IL-8 by ELISA and followed up for 36 months. In addition, 20 sex and age matched normal volunteers were included as control.

Results: In AML patients, serum IL-8 was ranging from 5 to 200 pg/mL with a mean of 76.5 pg/mL. It was significantly higher among AML patients when compared to the control (76.5 vs 32.3 pg/mL). The mean did not show any significant relationship to patients’ sex or the FAB classification of AML (p>0.05). While significant higher mean was observed among poor cytogenetic risk group (110.4 pg/mL) as well as among died patients (108.8 pg/mL) and refractory patients (84.2 pg/mL). In regard to survival, among those with IL-8>40 pg/mL, the mean survival time was higher in comparison to AML patients with IL-8 ≤ 40 pg/mL (34.6 months vs 26.3 months).

Conclusion: This study concluded that serum IL-8 concentration at presentation of AML patients is high and it could be used as a marker for risk stratification for AML patients.

PDF

Share this article

50+ Million Readerbase

Recommended Conferences

International Conference and Expo on Heart and Cardio Care

Amsterdam, Netherlands

International Conference and Expo on Digital Health

Paris, France

Journal Highlights

Google Scholar citation report
Citations: 443

Journal of Blood & Lymph received 443 citations as per Google Scholar report

Journal of Blood & Lymph peer review process verified at publons

Indexed In

Recommended Conferences

International Conference and Expo on Heart and Cardio Care

Amsterdam, Netherlands

International Conference and Expo on Digital Health

Paris, France

International Conference and Expo on Heart and Cardio Care

Amsterdam, Netherlands

International Conference and Expo on Digital Health

Paris, France
 
arrow_upward arrow_upward